Antimicrobial urinary catheters

Disinfection and Decontamination: Principles, Applications and Related Issues

Volumn , Issue , 2007, Pages 415-457

  Stickler, David J ^a   Sabbuba, Nora A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85020760634     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (152)

1. Darouiche, R.O., Device-associated infections: A macroproblem that starts with microadherence, Clin. Infect. Dis., 33, 1567, 2002.
2. Beeson, P.B., The case against the catheter, Am. J. Med., 24, 1, 1958.
3. Kunin, C.M., Can we build a better catheter? N. Eng. J. Med., 319, 365, 1988.
4. Jepsen, O.B. et al., Urinary tract infection and bacteraemia in hospitalised medical patients-a European multicentre prevalence survey on nosocomial infection, J. Hosp. Infect., 3, 241, 1982.
5. Warren, J.W. et al., The prevalence of urethral catheterization in Maryland nursing homes, Arch. Intern. Med., 149, 1535, 1989.
6. Zimakoff, J. et al., Management of urinary bladder function in Danish hospitals, nursing homes and home care, J. Hosp. Infect., 24, 183, 1993.
7. Sorbye, L.W. et al., Indwelling catheter use in home care: Elderly, aged 65p, in 11 different countries in Europe, Age Ageing, 34, 377, 2005.
8. Stark, R.P. and Maki, D.G., Bacteriuria in the catheterized patient: What quantitative level of bacteriuria is relevant? N. Eng. J. Med., 311, 560, 1984.
9. Garibaldi, R.A. et al., Factors predisposing to bacteriuria during indwelling urethral catheterization, N. Eng. J. Med., 291, 215, 1974.
10. Stamm, W.E., Catheter-associated urinary tract infections: Epidemiology, pathogenesis and prevention, Am. J. Med., 91, suppl. 3B, 65s, 1991.
11. Hayley, R.W. et al., The nationwide nosocomial infection rate, Am. J. Epidemiol., 121, 159, 1985.
12. Kass, E.H. and Schneidermann, L.J., Entry of bacteria into the urinary tracts of patients with in-lying catheters, N. Eng. J. Med., 256, 566, 1957.
13. Bultitude, M.J. and Eykyn, S., The relationship between the urethral flora and urinary infection in the catheterised male, Br. J. Urol., 45, 678, 1973.
14. Garibaldi, R.A. et al., Meatal colonization and catheter-associated bacteriuria, N. Eng. J. Med., 303, 316, 1980.
15. Fawcett, C. et al., A study of the skin flora of spinal cord injured patients, J. Hosp. Infect., 8, 149, 1986.
16. Tambyah, P.A., Catheter-associated urinary tract infections: Diagnosis and prophylaxis, Int. J. Antimicrob. Agents, 24S, S44, 2004.
17. Daifuku, R. and Stamm, W.E., Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters, JAMA, 252, 2028, 1984.
18. Nickel, J.C., Grant, S.K., and Costerton, J.W., Catheter-associated bacteriuria, an experimental study, Urology, 26, 369, 1985.
19. Nickel, J.C., Downey, J., and Costerton, J.W., Movement of Pseudomonas aeruginosa along catheter surfaces: A mechanism in pathogenesis of catheterassociated infection, Urology, 34, 93, 1992.
20. Tambyah, P.A., Halvorson, K.T., and Maki, D.G., A prospective study of pathogenesis of catheter-associated urinary tract infections, Mayo Clin. Proc., 74, 131, 1999.
21. Gillespie, W.A. et al., Does addition of disinfectant to urine drainage bags prevent infection in catheterised patients? Lancet, 1, 1037, 1983.
22. Kunin, C.M., The drainage bag additive saga, Infect. Control, 6, 261, 1985.
23. Matsukawa, M. et al., Bacterial colonization on intraluminal surface of urethral catheter, Urology, 65, 440, 2005.
24. Clayton, C.L., Chawla, J.C., and Stickler, D.J., Some observations on urinary tract infections in patients undergoing long-term bladder catheterisation, J. Hosp. Infect., 3, 39, 1982.
25. Warren, J.W. et al., A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters, J. Infect. Dis., 146, 719, 1982.
26. Kunin, C.M. et al., The association between the use of urinary catheters and morbidity and mortality among elderly patients in nursing homes, Am. J. Epidemiol., 135, 291, 1992.
27. Stickler, D.J. and Zimakoff, J., Complications of urinary tract infections associated with devices used for long-term bladder management, J. Hosp. Infect., 28, 177, 1994.
28. Griffith, D.P., Musher, D.M., and Itin, C., Urease: The preliminary cause of infection-induced urinary stones, Invest. Urol., 13, 346, 1976.
29. Ouslander, J.G., Greengold, B., and Chen, S., Complications of chronic indwelling urinary catheters among male nursing home patients: A prospective study, J. Urol., 138, 1191, 1987.
30. Warren, J.W. et al., Fever, bacteraemia and death as complications of bacteriuria in women with long-term urethral catheters, J. Infect. Dis., 155, 1151, 1987.
31. Galloway, A. et al., Serial concentrations of C-reactive protein as an indicator of urinary tract infection in patients with spinal cord injury, J. Clin. Path., 39, 851, 1986.
32. Warren, J.W., Muncie, H.L., and Hall-Craggs, M., Acute pyelonephritis associated with bacteriuria during long-term catheterization: A prospective clinicopathological study, J. Infect. Dis., 158, 1341, 1988.
33. Krieger, J.N., Kaiser, D.L., and Wenzel, R.P., Urinary tract etiology of bloodstream infections in hospitalized patients, J. Infect. Dis., 148, 57, 1983.
34. Bryan, C.S. and Reynolds, K.L., Hospital acquired bacteremic urinary tract infection: Epidemiology and outcome, J. Urol., 132, 494, 1984.
35. Saint, S., Clinical and economic consequences of nosocomial catheter-related bacteriuria, Am. J. Infect. Control, 28, 68, 2000.
36. Rudman, D. et al., Clinical correlates of bacteremia in a veterans administration extended care facility, J. Am. Geriatr. Soc., 36, 726, 1988.
37. Maki, D.G. and Tambyah, P.A., Engineering out the risk of infection with urinary catheters, Emerging Infect. Dis., 7, 1, 2001.
38. Nicolle, L.E., Catheter-related urinary tract infection, Drugs Ageing, 22, 627, 2005.
39. Kunin, C.M., Urinary Tract Infections: Detection, Prevention and Management, 5th ed., Williams and Wilkins, Baltimore, 1997, Chapter 9.
40. Kunin, C.M., Chin, Q.F., and Chambers, S., Formation of encrustations on indwelling catheters in the elderly: A comparison of different types of catheter materials in “blockers” and 'ʼnon-blockers,'' J. Urol., 138, 899, 1987.
41. Mobley, H.T.L. and Warren, J.W., Urease-positive bacteriuria and obstruction of long-term catheters, J. Clin. Microbiol., 25, 2216, 1987.
42. Kohler-Ockmore, J. and Feneley, R.C.L., Long-term catheterisation of the bladder: Prevalence and morbidity, Br. J. Urol., 77, 347, 1996.
43. Stickler, D.J. and Chawla, J.C., The role of antiseptics in the management of patients with long-term catheters, J. Hosp. Infect., 10, 219, 1987.
44. Stickler, D.J., Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: A perspective from the study of catheter biofilms, J. Appl. Microbiol., 92, suppl. 163S, 2002.
45. Southampton Control of Infection Team, Evaluation of aseptic techniques and chlorhexidine on the rate of catheter-associated urinary tract infection, Lancet, 1, 89, 1982.
46. Walker, E.M. and Lowes, J.A., An investigation into in vitro methods for the detection of chlorhexidine resistance, J. Hosp. Infect., 6, 389, 1985.
47. Dance, D.A.B. et al., Ahospital outbreak caused by a chlorhexidine and antibiotic resistant Proteus mirabilis, J. Hosp. Infect., 10, 10, 1987.
48. Butler, H.K. and Kunin, C.M., Evaluation of polymyxin lubricant and impregnated catheters, J. Urol., 100, 560, 1968.
49. Guggenbichler, J.P. et al., A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters, Infection, 27, suppl 1, S16, 1999.
50. Kunin, C.M. and Steele, C., Culture of the surfaces of urinary catheters to sample urethral flora and study the effect of antimicrobial therapy, J. Clin. Microbiol., 21, 902, 1985.
51. Danese, P.N., Antibiofilm approaches: Prevention of catheter colonization, Chem. Biol., 9, 873, 2002.
52. Knudsen, B.E., Chew, B.H., and Denstedt, J.D., Drug-eluting biomaterials in urology: The time is ripe, BJU Int., 95, 726, 2005.
53. Ohkawa, M. et al., Bacterial and crystal adherence to the surfaces of indwelling urethral catheters, J. Urol., 143, 717, 1990.
54. Santin, M. et al., Effect of the urine conditioning film on ureteral stent encrustation and characterization of its protein composition, Biomaterials, 20, 1245, 1999
55. McLean, R.J.C., Stickler, D.J., and Nickel, J.C., Biofilm mediated calculus formation in the urinary tract, Cells Mater., 6, 165, 1996.
56. Russell, A.D., Antimicrobial activity of silver, Prog. Med. Chem., 31, 351, 1994.
57. Darouiche, R.O., Anti-infective efficacy of silver-coated medical prostheses, Clin. Infect. Dis., 29, 1371, 1999.
58. Schierholz, J.M. et al., Antiinfective and encrustation-inhibiting materials- myth and facts, Int. J. Antimicrob. Agents, 19, 511, 2002.
59. Kumon, et al., Catheter-associated urinary tract infections: Impact of catheter materials on their management, Int. J. Antimicrob. Agents, 17, 311, 2001.
60. Rösch, W. and Lugauer, S., Catheter-associated infections in urology: Possible use of silver-impregnated catheters and the Erlanger silver catheter, Infection, 27, suppl 1, S74, 1999.
61. Davis, C.P. et al., Electrode and bacterial survival with iontophoresis in synthetic urine, J. Urol., 147, 1310, 1992.
62. Shafik, A., The electrified catheter: Role in sterilizing urine and decreasing bacteriuria, World J. Urol., 11, 183, 1993.
63. Chakravarti, A. et al., An electrified catheter to resist encrustation by Proteus mirabilis biofilm, J. Urol., 174, 1129, 2005.
64. Johnson, J.R. et al., Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: Clinical and microbiologic correlates, J. Infect. Dis., 162, 1145, 1990.
65. Riley, D.K. et al., A large randomized clinical trial of a silver-impregnated urinary catheter: Lack of efficiency and staphylococcal superinfection, Am. J. Med., 98, 349, 1995.
66. Davenport, K. and Keeley, F.X., Evidence for the use of silver-alloy-coated urethral catheters, J. Hosp. Infect., 60, 298, 2005.
67. Lundeberg, T., Prevention of catheter-associated urinary tract infections by the use of silver-impregnated catheters, Lancet, 2, 1031, 1986.
68. Liedberg, H. and Lundberg, T., Silver alloy coated catheters reduce catheterassociated bacteriuria, Br. J. Urol., 65, 379, 1990.
69. Liedberg, H., Lundberg, T., and Ekman, P., Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria, Eur. Urol., 17, 236, 1990.
70. Verleyen, P. et al., Clinical application of the Bardex IC Foley catheter, Eur. Urol., 36, 240, 1999.
71. Ahearn, D.G. et al., Effects of hydrogel/silver coatings on in vitro adhesions to catheters of bacteria associated with urinary tract infections, Curr. Microbiol., 41, 120, 2000.
72. Karchmer, T.B. et al., A randomized crossover study of silver-coated urinary catheters in hospitalized patients, Arch. Intern. Med., 160, 3294, 2000.
73. Garner, J.S. et al., CDC definitions for nosocomial infections, Am. J. Infect. Control, 16, 128, 1988.
74. Thibon, P. et al., Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections, J. Hosp. Infect., 45, 117, 2000.
75. Niël-Weise, B.S., Arend, S.M., and van den Broek, P.J., Is there evidence for recommending silver-coated urinary catheters in guidelines? J. Hosp. Infect., 52, 81, 2002.
76. Saint, S.J. et al., The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: A meta-analysis, Am. J. Med., 105, 236, 1998.
77. Rupp, M.E. et al., Effect of silver-coated urinary catheters: Efficacy, cost-effectiveness and antimicrobial resistance, Am. J. Infect. Control, 32, 445, 2004.
78. Lai, K.K. and Fontecchio, S.A., Use of silver-hydrogel urinary catheters on incidence of catheter-associated urinary tract infections in hospitalized patients, Am. J. Infect. Control, 30, 221, 2002.
79. Saint, S. et al., The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection, Arch. Intern. Med., 160, 2670, 2000.
80. Plowman, R. et al., An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients, J. Hosp. Infect., 48, 33, 2001.
81. Srinivasan, A. et al., A prospective trial of a novel silicone-based, silver-coated Foley catheter for the prevention of nosocomial urinary tract infections, Infect. Control Hosp. Epidemiol., 27, 38, 2006.
82. Darouiche, R.O. et al., Antimicrobial activity and durability of a novel antimicrobial-impregnated bladder catheter, Int. J. Antimicrob. Agents, 8, 243, 1997.
83. Darouiche, R.O., Safar, H., and Raad, I.I., In vitro efficacy of antimicrobialcoated bladder catheters in inhibiting bacterial migration along catheter surface, J. Infect. Dis., 176, 1109, 1997.
84. Darouiche, R.O. et al., Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: A prospective randomized multicentre clinical trial, Urology, 54, 976, 1999.
85. Lambert, H.P. and O’Grady, F.W., Antibiotic and Chemotherapy, 6th ed., Churchill Livingstone, Edinburgh, 1992, pp. 181-184.
86. Johnson, J.R., Berggren, T., and Conway, A.J., Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens, Antimicrob. Agents Chemother., 37, 2033, 1993.
87. Johnson, J.R., Delavari, P., and Azar, M., Activities of a nitrofurazone-containing catheter and a silver hydrogel catheter against multi-drug resistant bacteria characteristic of catheter-associated urinary tract infection, Antimicrob. Agents Chemother., 43, 2990, 1999.
88. Lee, S.J. et al., A comparative multicentre study on the incidence of catheterassociated urinary tract infection between nitrofurazone-coated and silicone catheters, Int. J. Antimicrob. Agents, 24S, S65, 2004.
89. Johnson, J.R., Kuskowski, M.A., and Wilt, T.J., Systematic review: Antimicrobial catheters to prevent catheter-associated urinary tract infection in hospitalized patients, Ann. Intern. Med., 144, 116, 2006.
90. Maki, D.G., Knasinski, V., and Tambyah, P.A., A prospective investigatorblinded trial of a novel nitrofurazone-impregnated urinary catheter, [Abstract] Infect. Control Hosp. Epidemiol., 18, P50, 1997.
91. Al-Habdan, I. et al., Assessment of nosocomial urinary tract infections in orthopaedic patients: A prospective and comparative study using two different catheters, Int. Surg., 88, 152, 2003.
92. Schierholz, J.M. et al., The efficacy of alloy-coated urinary catheters in preventing urinary tract infection, Am. J. Med., 107, 534, 1999.
93. Brosnahan, J., Jull, A., and Tracy, C., Types of urethral catheters for management of short-term voiding problems in hospitalised adults, Cochrane Database Syst. Rev. Issue, 1, 1, 2004.
94. Trautner, B.W., Hull, R.A., and Darouiche, R.O., Prevention of catheter-associated urinary tract infection, Curr. Opin. Infect. Dis., 18, 37, 2005.
95. Orr, P. et al., Febrile urinary infection in the institutionalized elderly, Am. J. Med., 100, 71, 1996.
96. Tambyah, P.A. and Maki, D.G., Catheter-associated urinary tract infection is rarely symptomatic: A prospective study of 1497 catheterized patients, Arch. Intern. Med., 160, 678, 2000.
97. Richards, C.L. et al., Development and characterization of an infection inhibiting urinary catheter, ASAIO J., 49, 449, 2003.
98. Gaonkar, T.A., Sampath, L.A., and Modak, S.M., Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model, Infect. Control Hosp. Epidemiol., 24, 506, 2003.
99. Malcolm, R.K. et al., Controlled release of a model antibacterial drug from a novel self-lubricating silicone biomaterial, J. Control. Rel., 97, 313, 2004.
100. Cho, Y.H. et al., Prophylactic efficacy of a new gentamicin-releasing urethral catheter in short-term catheterized rabbits, Br. J. Urol. Int., 87, 104, 2001.
101. Cho, Y.W. et al., Gentamicin-releasing urethral catheter for short-term catheterization, J. Biomater. Sci. Polym. Ed., 14, 963, 2003.
102. Park, J.H. et al., Norfloxacin-releasing urethral catheter for long-term catheterization, J. Biomater. Sci. Polym. Ed., 14, 951, 2003.
103. Kwok, C.S., Horbett, T.A., and Ratner, B.D., Controlled release of antibiotics through a plasma-deposited thin film barrier, J. Control. Rel., 62, 301, 1999.
104. Pugach, J.L. et al., Antibiotic hydrogel coated Foley catheters for prevention of urinary tract infection in a rabbit model, J. Urol., 162, 883, 1999.
105. Kono, K., Thermosensitive polymer-modified liposomes, Adv. Drug Delivery Rev., 53, 307, 2001.
106. Maeda, M., Kumano, A., and Tirrell, D.A., Hp-induced release of contents of phosphatidylcholine vesicles bearing surface-bound polyelectrolyte chains, J. Am. Chem. Soc., 110, 7455, 1988.
107. Meers, P., Enzyme-activated targeting of liposomes, Adv. Drug Delivery Rev., 53, 265, 2001.
108. Woo, G.L.Y., Mittleman, M.W., and Santerre, J.P., Synthesis and characterization of a novel biodegradable antimicrobial polymer, Biomaterials, 21, 1235, 2000.
109. Tanihara, M. et al., A novel microbial infection-responsive drug release system, J. Pharm. Sci., 88, 510, 1999.
110. Qiu, Y. and Park, K., Environment-sensitive hydrogels for drug delivery, Adv. Drug Delivery Rev., 53, 321, 2001.
111. Kwok, C.S. et al., Self-assembledmolecular structures as ultrasonically-responsive barriermembranes for pulsatile drug delivery, J. Biomed. Mater. Res., 57, 151, 2001.
112. Norris, P. et al., Ultrasonically controlled release of ciprofloxacin from self-assembled coatings on poly(2-hydroxyethyl methacrylate) hydrogels for Pseudomonas aeruginosa biofilm prevention, Antimicrob. Agents Chemother., 49, 4272, 2005.
113. Jones, D.S., Andrews, G.P., and Gorman, S.P., Characterization of crosslinking effects on the physicochemical and drug diffusional properties of cationic hydrogels designed as bioactive urological biomaterials, J. Pharm. Pharmacol., 57, 1251, 2005.
114. Mobley, H.L.T., Virulence of Proteus mirabilis. In Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, Mobley, H.L.T. and Warren, J.W., Eds., ASM Press, Washington, 1996, pp. 245-269.
115. Choong, S. et al., Catheter-associated urinary tract infection and encrustation, Int. J. Antimicrob. Agents, 17, 305, 2001.
116. Suller, M.T.E. et al., Factors modulating thepHat which calcium and magnesium phosphates precipitate from human urine, Urol. Res., 33, 254, 2005.
117. Morris, N.S., Stickler, D.J., and Winters, C., Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br. J. Urol. Int., 80, 58, 1997.
118. Capewell, A.E. and Morris, S.L., Audit of catheter management provided by district nurses and continence advisors, Br. J. Urol. 71, 259, 1993.
119. Getliffe, K.A. and Mulhall, A.B., The encrustation of indwelling catheters, Br. J. Urol., 67, 337, 1991.
120. Cox, A.J. and Hukins, D.W.L., Morphology of mineral deposits on encrusted urinary catheters investigated by scanning electron microscopy, J. Urol., 142, 1347, 1989.
121. Hedelin, H. et al., The composition of catheter encrustations, including the effect of allopurinol treatment, Br. J. Urol., 56, 250, 1984.
122. Cox, A.J., Hukins, D.W.L., and Sutton, T.M., Infection of catheterised patients: Bacterial colonization of encrusted Foley catheters shown by scanning electron microscopy, Urol. Res., 17, 349, 1989.
123. Stickler, D.J. et al., Proteus mirabilis biofilms and the encrustation of urethral catheters, Urol. Res., 21, 407, 1993.
124. Stickler, D.J. et al., Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm? Urol. Res., 31, 306, 2003.
125. Kunin, C.M., Blockage of urinary catheters: Role of microorganisms and constituents of urine on the formation of encrustations, J. Clin. Epidemiol., 42, 835, 1989.
126. Morris, N.S., Stickler, D.J., and McLean, R.J.C., The development of bacterial biofilms on indwelling urethral catheters, World J. Urol., 17, 345, 1999.
127. Clapham, L. et al., The influence of bacteria on struvite crystal habit and its importance in urinary stone formation, J. Crystl. Growth, 104, 475, 1990.
128. Dumanski, A.J. et al., Unique ability of Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi, Infect. Immun., 62, 2998, 1994.
129. Stickler, D.J. et al., Observations on the adherence of Proteus mirabilis onto polymer surfaces, J. Appl. Microbiol., 100, 1028, 2006.
130. Morris, N.S. and Stickler, D.J., Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine, J. Hosp. Infect., 39, 227, 1998.
131. Morgan, S.D. and Stickler, D.J., The development of crystalline Proteus mirabilis biofilms on Foley catheters, Clin. Microbiol. Infect., 11, suppl 2, 541, 2005.
132. Bibby, J.M., Cox, A.J., and Hukins, D.W.L., Feasibility of preventing encrustation on urinary catheters, Cells Mater., 2, 183, 1995.
133. Rosenheim, M.L., Mandelic acid in the treatment of urinary tract infections, Lancet, I, 1032, 1935.
134. Stickler, D.J., Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: A perspective from the study of catheter biofilms, J. Appl. Microbiol. Symp., 92, suppl, 163S, 2002.
135. Stickler, D.J., Jones, G.L., and Russell, A.D., Control of encrustation and blockage of Foley catheters, Lancet, 361, 1435, 2003.
136. Jones, G.L. et al., A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan, Eur. Urol., 48, 838, 2005.
137. Jones, R.D. et al., Triclosan: A review of its effectiveness and safety in healthcare settings, Am. J. Infect. Control, 28, 184, 2000.
138. Sreenivasan, P. and Gaffar, A., Antiplaque biocides and bacterial resistance: A review, J. Clin. Periodontol., 29, 965, 2002.
139. McBain, A.J. et al., Exposure of sink drain microcosms to triclosan: Population dynamics and antimicrobial susceptibility, Appl. Environ. Microbiol., 69, 5433, 2003.
140. Russell, A.D., Whither triclosan? J. Antimicrob. Chemother., 53, 693, 2004.
141. Barganza, H.N. and Leonard, P.A., Triclosan: Applications and safety, Am. J. Infect. Control, 24, 209, 1996.
142. Jones, G.L. et al., Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters, J. Antimicrob. Chemother., 57, 266, 2006.
143. Stickler, D.J. et al., Studies on the formation of crystalline bacterial biofilms on urethral catheters, Eur. J. Clin. Infect. Dis., 17, 649, 1998.
144. Carlsson, S. et al., Intravesical nitric oxide delivery for prevention of catheterassociated urinary tract infections, Antimicrob. Agents Chemother., 49, 2352, 2005.
145. Trautner, B.W. and Darouiche, R.O., Catheter-associated infections: Pathogenesis affects prevention, Arch. Intern. Med., 164, 842, 2004.
146. Reid, G., Bruce, A., and Taylor, M., Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrent urinary tract infection, Clin. Ther., 14, 11, 1992.
147. Bruce, A. and Reid, G., Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infection, Can. J. Microbiol., 34, 339, 1988.
148. Hull, R. et al., Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients, J. Urol., 163, 872, 2000.
149. Darouiche, R.A. et al., Pilot trial of bacterial interference for preventing urinary tract infection, Urology, 58, 339, 2001.
150. Trautner, B.W., Hull, R.A., and Darouiche, R.O., Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens, Urology, 61, 1059, 2003.
151. Trautner, B.W., Hull, R.A., and Darouiche, R.O., Colicins prevent colonization of urinary catheters, J. Antimicrob. Chemother., 56, 413, 2005.
152. Stickler, D.J., Biofilus catheters and urinary tract infections, Eur. Urol. Update, 5, 1, 1996.